Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 4/20 | 0.39 |
| ▸ | TGM2 | P21980 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29029202 | 0.85 | ELANE (0.42) | ELANEALDH1A1HTTATMLMNA | |
| SCHEMBL28701229 | 0.81 | ALDH1A1 (0.41) | TGM2ALDH1A1SMN1; SMN2STAT3ACHE | |
| SCHEMBL28381315 | 0.73 | CHRNA7 (0.43) | TGM2ALDH1A1SMN1; SMN2STAT3ACHE | |
| SCHEMBL25553550 | 0.71 | CHRNA7 (0.37) | TGM2ALDH1A1STAT3ACHEMEN1 | |
| SCHEMBL8977935 | 0.69 | TGM2 (0.38) | TGM2ALDH1A1SMN1; SMN2STAT3PKM | |
| SCHEMBL10458582 | 0.68 | CYP2A6 (0.38) | LMNATDP1 | |
| SCHEMBL29034776 | 0.67 | TPMT (0.35) | ALDH1A1CYP3A4 | |
| SCHEMBL27628648 | 0.67 | CYP1A2 (0.44) | TGM2ALDH1A1SMN1; SMN2ALOX5LMNA | |
| SCHEMBL21294950 | 0.67 | MAPT (0.41) | ELANEALDH1A1HTTATMNPSR1 | |
| SCHEMBL61038 | 0.66 | CYP3A4 (0.50) | ALDH1A1LMNAHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116856-A1 | METHOD FOR PREPARING META-(CHIRAL ALLYL)-SUBSTITUTED PYRIDINE COMPOUND | NANKAI UNIVERSITY (CN) | 2026-04-30 | — | — | US | disclosed |
| CN-116396211-B | Method for preparing meta-chiral allyl substituted pyridine compound | 南开大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-116396211-A | Method for preparing meta-chiral allyl substituted pyridine compound | 南开大学 | 2023-07-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116856-A1 | METHOD FOR PREPARING META-(CHIRAL ALLYL)-SUBSTITUTED PYRIDINE COMPOUND | GAPVD1, TDO2, NOD1 | ELANE 4346/4885TGM2 1295/4885ALDH1A1 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.